You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

TOVALT ODT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Tovalt Odt patents expire, and what generic alternatives are available?

Tovalt Odt is a drug marketed by Biovail Labs Intl and is included in one NDA.

The generic ingredient in TOVALT ODT is zolpidem tartrate. There are thirty-three drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the zolpidem tartrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Tovalt Odt

A generic version of TOVALT ODT was approved as zolpidem tartrate by ACME LABS on April 23rd, 2007.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TOVALT ODT?
  • What are the global sales for TOVALT ODT?
  • What is Average Wholesale Price for TOVALT ODT?
Summary for TOVALT ODT
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 47
DailyMed Link:TOVALT ODT at DailyMed
Drug patent expirations by year for TOVALT ODT

US Patents and Regulatory Information for TOVALT ODT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biovail Labs Intl TOVALT ODT zolpidem tartrate TABLET, ORALLY DISINTEGRATING;ORAL 021412-001 Apr 25, 2007 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Biovail Labs Intl TOVALT ODT zolpidem tartrate TABLET, ORALLY DISINTEGRATING;ORAL 021412-002 Apr 25, 2007 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.